FASEB Conference: Genome Engineering: Research and...
CMN Briefs
May. 7, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Be Biopharma
Company type: Therapeutics
Main focus: B cell engineering
Company stage: Pre-clinical
Diseases: Cancer
Genome-editing tool: CRISPR
Funding stage: Series B
Location: Cambridge, MA, USA
Website: https://www.be.bio
Pipeline: Not disclosed
Partners:
Be Biopharma is a pre-clinical-stage company focused on the engineering of B cells via CRISPR, to produce engineered B Cell medicines (BeCMs). Once differentiated in plasma cells ex vivo, BeCMs can be infused into patients and act as cell factories to produce the required therapeutic molecules.
